4//SEC Filing
Sofinnova Venture Partners X, L.P. 4
Accession 0001104659-21-016806
CIK 0001641281other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 6:04 PM ET
Size
18.2 KB
Accession
0001104659-21-016806
Insider Transaction Report
Form 4
Sofinnova Management X, L.L.C.
10% Owner
Transactions
- Conversion
Common Stock
2021-02-09+1,200,228→ 2,304,437 total - Conversion
Series C-2 Preferred Stock
2021-02-09−1,200,228→ 0 total→ Common Stock (1,200,228 underlying) - Conversion
Common Stock
2021-02-09+1,104,209→ 1,104,209 total - Purchase
Common Stock
2021-02-09$20.00/sh+450,000$9,000,000→ 2,754,437 total - Conversion
Series C-1 Preferred Stock
2021-02-09−1,104,209→ 0 total→ Common Stock (1,104,209 underlying)
Katabi Maha
10% Owner
Transactions
- Conversion
Common Stock
2021-02-09+1,200,228→ 2,304,437 total - Conversion
Series C-1 Preferred Stock
2021-02-09−1,104,209→ 0 total→ Common Stock (1,104,209 underlying) - Conversion
Common Stock
2021-02-09+1,104,209→ 1,104,209 total - Purchase
Common Stock
2021-02-09$20.00/sh+450,000$9,000,000→ 2,754,437 total - Conversion
Series C-2 Preferred Stock
2021-02-09−1,200,228→ 0 total→ Common Stock (1,200,228 underlying)
Sofinnova Venture Partners X, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2021-02-09+1,200,228→ 2,304,437 total - Conversion
Series C-1 Preferred Stock
2021-02-09−1,104,209→ 0 total→ Common Stock (1,104,209 underlying) - Conversion
Common Stock
2021-02-09+1,104,209→ 1,104,209 total - Purchase
Common Stock
2021-02-09$20.00/sh+450,000$9,000,000→ 2,754,437 total - Conversion
Series C-2 Preferred Stock
2021-02-09−1,200,228→ 0 total→ Common Stock (1,200,228 underlying)
POWELL MICHAEL
10% Owner
Transactions
- Conversion
Series C-2 Preferred Stock
2021-02-09−1,200,228→ 0 total→ Common Stock (1,200,228 underlying) - Purchase
Common Stock
2021-02-09$20.00/sh+450,000$9,000,000→ 2,754,437 total - Conversion
Series C-1 Preferred Stock
2021-02-09−1,104,209→ 0 total→ Common Stock (1,104,209 underlying) - Conversion
Common Stock
2021-02-09+1,104,209→ 1,104,209 total - Conversion
Common Stock
2021-02-09+1,200,228→ 2,304,437 total
Footnotes (3)
- [F1]The Series C-1 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's initial public offering (the "IPO") and had no expiration date.
- [F2]The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy, Maha Katabi, and Michael F. Powell are the managing members of SM X and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein.
- [F3]The Series C-2 Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:1 basis immediately upon closing of the Issuer's IPO and had no expiration date.
Documents
Issuer
Bolt Biotherapeutics, Inc.
CIK 0001641281
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001680200
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 6:04 PM ET
- Size
- 18.2 KB